| Bioactivity | Bamocaftor (VX-659) is a cystic fibrosis transmembrane conductance regulator (CFTR) corrector designed to restore F508del-CFTR protein function. Bamocaftor can be used combine with Tezacaftor and Ivacaftor in cystic fibrosis research[1]. | ||||||||||||
| Invitro | Bamocaftor is a CFTR corrector designed to restore F508del-CFTR protein function[1]. | ||||||||||||
| Name | Bamocaftor | ||||||||||||
| CAS | 2204245-48-5 | ||||||||||||
| Formula | C28H32F3N5O4S | ||||||||||||
| Molar Mass | 591.64 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Ghelani DP, et al. Emerging Cystic Fibrosis Transmembrane Conductance Regulator Modulators as New Drugs for Cystic Fibrosis: A Portrait of in Vitro Pharmacology and Clinical Translation. |
Bamocaftor
CAS: 2204245-48-5 F: C28H32F3N5O4S W: 591.64
Bamocaftor (VX-659) is a cystic fibrosis transmembrane conductance regulator (CFTR) corrector designed to restore F508de
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.